{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:25:03Z","timestamp":1790169903657,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81102478"],"award-info":[{"award-number":["81102478"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81172799"],"award-info":[{"award-number":["81172799"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81273231"],"award-info":[{"award-number":["81273231"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ejphar.2013.09.050","type":"journal-article","created":{"date-parts":[[2013,10,4]],"date-time":"2013-10-04T23:52:58Z","timestamp":1380930778000},"page":"86-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["5\u2032-Triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells"],"prefix":"10.1016","volume":"721","author":[{"given":"Xiaojuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyu","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongbin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2013.09.050_bib1","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.3390\/v2071394","article-title":"Innate antiviral immune responses to hepatitis B virus","volume":"2","author":"Ait-goughoulte","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.ejphar.2013.09.050_bib2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2013.09.050_bib3","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1086\/656624","article-title":"Review of hepatitis B therapeutics","volume":"51","author":"Bhattacharya","year":"2010","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.ejphar.2013.09.050_bib4","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/nri2436","article-title":"Viral evasion and subversion of pattern-recognition receptor signalling","volume":"8","author":"Bowie","year":"2008","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.ejphar.2013.09.050_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.molcel.2007.10.032","article-title":"The C-terminal regulatorydomain is the RNA 5\u2032-triphosphate sensor of RIG-I","volume":"29","author":"Cui","year":"2008","journal-title":"Molecular Cell"},{"key":"10.1016\/j.ejphar.2013.09.050_bib6","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1182\/blood-2009-02-206706","article-title":"TEL-AML1 regulation of survivin and apoptosis via miRNA-494 and miRNA-320a","volume":"116","author":"Diakos","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2013.09.050_bib7","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1056\/NEJMra0801644","article-title":"Hepatitis B virus infection","volume":"359","author":"Dienstag","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.ejphar.2013.09.050_bib8","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1002\/hep.22920","article-title":"Benefits and risks of nucleoside analog therapy for hepatitis B","volume":"49","author":"Dienstag","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2013.09.050_bib9","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1053\/j.gastro.2011.05.001","article-title":"5\u2032 Triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human liver cells and mice","volume":"141","author":"Ebert","year":"2011","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.ejphar.2013.09.050_bib10","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1136\/gut.2004.060327","article-title":"Response to interferon alfa is hepatitis B virus genotype dependent: genotype A is more sensitive to interferon than genotype D","volume":"54","author":"Erhardt","year":"2005","journal-title":"Gut"},{"issue":"Suppl","key":"10.1016\/j.ejphar.2013.09.050_bib11","first-page":"700A","article-title":"HBV genotypes are the strongest predictors of response to interferon-alfa treatment: multivariate evaluation in 1229 hepatitis B patients [abstract]","volume":"48","author":"Erhardt","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2013.09.050_bib12","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/gut.2008.163600","article-title":"Early kinetics of innate and adaptive immune responses during hepatitis B virus infection","volume":"58","author":"Fisicaro","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2013.09.050_bib13","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1111\/j.1572-0241.2006.00812.x","article-title":"Successful treatment with peginterferon alpha-2b of HbeAg-positive HBV non-responders to standard interferon or lamivudine","volume":"101","author":"Flink","year":"2006","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.ejphar.2013.09.050_bib14","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4254\/wjh.v4.i3.74","article-title":"Hepatitis B: epidemiology and prevention in developing countries","volume":"27","author":"Franco","year":"2012","journal-title":"World Journal of Hepatology"},{"key":"10.1016\/j.ejphar.2013.09.050_bib15","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1525-0016(03)00244-2","article-title":"Small interfering RNA inhibits hepatitis B virus replication in mice","volume":"8","author":"Giladi","year":"2003","journal-title":"Molecular Therapy"},{"key":"10.1016\/j.ejphar.2013.09.050_bib16","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.284.5415.825","article-title":"Viral clearance without destruction of infected cells during acute HBV infection","volume":"284","author":"Guidotti","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2013.09.050_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0014-5793(03)00400-9","article-title":"Short interfering RNA-directed inhibition of hepatitis B virus replication","volume":"543","author":"Hamasaki","year":"2003","journal-title":"FEBS Letters"},{"key":"10.1016\/j.ejphar.2013.09.050_bib18","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/hep.24505","article-title":"Reversal of hepatitis B virus-induced immune tolerance by an immunostimulatory 3p-HBx-siRNAs in a retinoic acid inducible gene I-dependent manner","volume":"54","author":"Han","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2013.09.050_bib19","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1126\/science.1132505","article-title":"5\u2032-Triphosphate RNA is the ligand for RIG-I","volume":"314","author":"Hornung","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2013.09.050_bib20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nbt940","article-title":"Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase","volume":"22","author":"Kim","year":"2004","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.ejphar.2013.09.050_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0016-5085(03)00720-0","article-title":"Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA","volume":"125","author":"Klein","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2013.09.050_bib22","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1053\/jhep.2003.50416","article-title":"Inhibition of HBV replication by siRNA in a stable HBV-producing cell line","volume":"38","author":"Konishi","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2013.09.050_bib23","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.cyto.2008.07.009","article-title":"Innate immune response to viral infection","volume":"43","author":"Koyama","year":"2008","journal-title":"Cytokine"},{"issue":"23","key":"10.1016\/j.ejphar.2013.09.050_bib24","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMe0808185","article-title":"Chronic hepatitis B\u2014new goals, new treatment","volume":"359","author":"Lai","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.ejphar.2013.09.050_bib25","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.3748\/wjg.v13.i16.2324","article-title":"Combination of small interfering RNA and lamivudine on inhibition of human B virus replication in HepG2.2.15 cells","volume":"13","author":"Li","year":"2007","journal-title":"World Journal of Gastroenterology"},{"key":"10.1016\/j.ejphar.2013.09.050_bib26","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nbt824","article-title":"Inhibition of hepatitis B virus in mice by RNA interference","volume":"21","author":"McCaffrey","year":"2003","journal-title":"Nature Biotechnology"},{"key":"10.1016\/j.ejphar.2013.09.050_bib27","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.immuni.2007.08.012","article-title":"Innate recognition of viruses","volume":"27","author":"Pichlmair","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.ejphar.2013.09.050_bib28","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/nm.1887","article-title":"5\u2032-Triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma","volume":"14","author":"Poeck","year":"2008","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/j.ejphar.2013.09.050_bib29","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1572-0241.2006.01006.x","article-title":"Effect of lowering HBV DNA levels by initial antiviral therapy before adding immunomodulator on treatment of chronic hepatitis B","volume":"102","author":"Sarin","year":"2007","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.ejphar.2013.09.050_bib30","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1073\/pnas.84.4.1005","article-title":"Production of hepatitis B virus particles in HepG2 cells transfected with cloned hepatitis B virus DNA","volume":"84","author":"Sells","year":"1987","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.ejphar.2013.09.050_bib31","doi-asserted-by":"crossref","first-page":"e30802","DOI":"10.1371\/journal.pone.0030802","article-title":"Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling","volume":"7","author":"Sun","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2013.09.050_bib32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/135965350901400115","article-title":"Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro","volume":"14","author":"Vincent","year":"2009","journal-title":"Antiviral Therapy"},{"key":"10.1016\/j.ejphar.2013.09.050_bib33","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1081\/NCN-200059303","article-title":"Incorporation of ribomucleoside 5\u2032-(alpha-P-borano) triphosphates into a 20-mer RNA by T7 RNA polymerase","volume":"24","author":"Wan","year":"2005","journal-title":"Nucleosides, Nucleotides and Nucleic Acids"},{"key":"10.1016\/j.ejphar.2013.09.050_bib34","doi-asserted-by":"crossref","first-page":"9913","DOI":"10.1073\/pnas.0504273102","article-title":"Interferon prevents formation of replication-competent hepatitis B virus RNA containing nucleocapsids","volume":"102","author":"Wieland","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.ejphar.2013.09.050_bib35","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1073\/pnas.0401771101","article-title":"Genomic analysis of the host response to hepatitis B virus infection","volume":"101","author":"Wieland","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.ejphar.2013.09.050_bib36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.virusres.2005.04.001","article-title":"Inhibition of Hepatitis B virus gene expression by single and dual small interfering RNA treatment","volume":"112","author":"Wu","year":"2005","journal-title":"Virus Research"},{"key":"10.1016\/j.ejphar.2013.09.050_bib37","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1074\/jbc.M609293200","article-title":"RNA interference silencing of the adaptor molecules ShcC and Fe65 differentially affect amyloid precursor protein processing and Abeta generation","volume":"282","author":"Xie","year":"2007","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.ejphar.2013.09.050_bib38","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.4049\/jimmunol.175.5.2851","article-title":"Shared and unique functions of the DExD\/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity","volume":"175","author":"Yoneyama","year":"2005","journal-title":"Journal of Immunology"},{"issue":"1","key":"10.1016\/j.ejphar.2013.09.050_bib39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.virusres.2012.10.027","article-title":"The response to interferon is influenced by hepatitis B virus genotype in vitro and in vivo","volume":"171","author":"Zhang","year":"2013","journal-title":"Virus Research"},{"issue":"4","key":"10.1016\/j.ejphar.2013.09.050_bib40","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1086\/511042","article-title":"Genotype B and younger patient age associated with better response to low-dose therapy: a trial with pegylated\/nonpegylated interferon-alpha-2b for hepatitis B e antigen-positive patients with chronic hepatitis B in China","volume":"44","author":"Zhao","year":"2007","journal-title":"Clinical Infectious Diseases"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913007140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913007140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T22:01:22Z","timestamp":1688508082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299913007140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":40,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0014299913007140"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.09.050","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5\u2032-Triphosphate-siRNA activates RIG-I-dependent type I interferon production and enhances inhibition of hepatitis B virus replication in HepG2.2.15 cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.09.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}